France Circulating Tumor Cells Market Size & Outlook
France circulating tumor cells market, 2018-2030 (US$M)
Related Markets
France circulating tumor cells market highlights
- The France circulating tumor cells market generated a revenue of USD 590.9 million in 2023 and is expected to reach USD 1,428.4 million by 2030.
- The France market is expected to grow at a CAGR of 13.4% from 2024 to 2030.
- In terms of segment, ctc detection & enrichment methods was the largest revenue generating technology in 2023.
- CTC Analysis is the most lucrative technology segment registering the fastest growth during the forecast period.
Circulating tumor cells market data book summary
| Market revenue in 2023 | USD 590.9 million |
| Market revenue in 2030 | USD 1,428.4 million |
| Growth rate | 13.4% (CAGR from 2023 to 2030) |
| Largest segment | Ctc detection & enrichment methods |
| Fastest growing segment | CTC Analysis |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CTC Detection & Enrichment Methods, CTC Direct Detection Methods, CTC Analysis |
| Key market players worldwide | Qiagen NV, Bio-Techne Corp, Praxis Precision Medicines Inc Ordinary Shares, Aviva PLC, Biocept Inc, Neurocrine Biosciences Inc, Greiner Bio-One, Miltenyi Biotec, Icon PLC, Ecolab Inc, Arcus Biosciences Inc, Epic Corp, Screen Holdings Co Ltd, Menarini Group, Vtex Ordinary Shares - Class A, Sysmex Corp, STEMCELL Technologies |
Other key industry trends
- In terms of revenue, France accounted for 5.2% of the global circulating tumor cells market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK circulating tumor cells market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 1,926.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Circulating Tumor Cells Market Scope
Circulating Tumor Cells Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
France circulating tumor cells market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to circulating tumor cells market will help companies and investors design strategic landscapes.
Ctc detection & enrichment methods was the largest segment with a revenue share of 65.8% in 2023. Horizon Databook has segmented the France circulating tumor cells market based on ctc detection & enrichment methods, ctc direct detection methods, ctc analysis covering the revenue growth of each sub-segment from 2018 to 2030.
French generic pharmaceutical market is expected to witness slow growth over the forecast period. The government highly influences the French generic market. The market is dominated by top players, with approximately 31% penetration of generics by volume.
The government plays a crucial role in approving and setting prices for generics, and as compared to other European countries, it is relatively less profitable. In addition, since January 2015, it has been mandatory for physicians to prescribe according to INN. Such factors could slow down the market growth of branded generics by promoting unbranded generics in the market.
However, certain government initiatives are expected to support market growth, such as incentives for physicians and pharmacists to prescribe biosimilar & substituting generic products, if an originator is prescribed.
Reasons to subscribe to France circulating tumor cells market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of France circulating tumor cells market databook
-
Our clientele includes a mix of circulating tumor cells market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France circulating tumor cells market , including forecasts for subscribers. This country databook contains high-level insights into France circulating tumor cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
France circulating tumor cells market size, by technology, 2018-2030 (US$M)
France Circulating Tumor Cells Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
